Abstract:Oxidative stress in the central nervous system mediates the increase in sympathetic tone that precedes the development of hypertension. We hypothesized that by transforming Angiotensin-II (AngII) into Ang-(1-7), ACE2 might reduce AngII-mediated oxidative stress in the brain and prevent autonomic dysfunction. To test this hypothesis, a relationship between ACE2 and oxidative stress was first confirmed in a mouse neuroblastoma cell line (Neuro2A cells) treated with AngII and infected with Ad-hACE2. ACE2 overexpression resulted in a reduction of reactive oxygen species (ROS) formation. In vivo, ACE2 knockout (ACE2(-/y)) mice and non-transgenic (NT) littermates were infused with AngII (10 days) and infected with Ad-hACE2 in the paraventricular nucleus (PVN). Baseline blood pressure (BP), AngII and brain ROS levels were not different between young mice (12 weeks). However, cardiac sympathetic tone, brain NADPH oxidase and SOD activities were significantly increased in ACE2(-/y). Post infusion, plasma and brain AngII levels were also significantly higher in ACE2(-/y), although BP was similarly increased in both genotypes. ROS formation in the PVN and RVLM was significantly higher in ACE2(-/y) mice following AngII infusion. Similar phenotypes, i.e. increased oxidative stress, exacerbated dysautonomia and hypertension, were also observed on baseline in mature ACE2(-/y) mice (48 weeks). ACE2 gene therapy to the PVN reduced AngII-mediated increase in NADPH oxidase activity and normalized cardiac dysautonomia in ACE2(-/y) mice. Altogether, these data indicate that ACE2 gene deletion promotes age-dependent oxidative stress, autonomic dysfunction and hypertension, while PVN-targeted ACE2 gene therapy decreases ROS formation via NADPH oxidase inhibition and improves autonomic function. Accordingly, ACE2 could represent a new target for the treatment of hypertension-associated dysautonomia and oxidative stress.

Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration

The attenuation of central angiotensin II-dependent pressor response and intra-neuronal signaling by intracarotid injection of nanoformulated copper/zinc superoxide dismutase

Neuronal Toxicity & Uptake of Cross‐Linked Copper/Zinc Superoxide Dismutase Nanozyme (cl‐SOD1 nano)

Nanoformulated Superoxide Dismutase 1 (SOD1): Implications for Angiotensin II (angii) and Brain‐related Cardiovascular Diseases

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Reactive oxygen/nitrogen species scavenging multi-enzyme mimetic ultrasmall calcium hexacyanoferrate (III) nanozyme for hypertension remedy

Cross-linked antioxidant nanozymes for improved delivery to CNS

A Novel Ultrasonic-Triggered Drug Release and Tracked Drug Delivery System Based on Gas-Filled BSA Microbubbles and Gelatin Nanogels

Zwitterionic Poly(Lysine Methacrylate) Brush As an Effective Carrier for Drug Delivery

Anti-Hypertensive Property of an NO Nanoparticle in an Adenine-Induced Chronic Kidney Disease Young Rat Model

ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function

Ultrathin Niobium Carbide MXenzyme for Remedying Hypertension by Antioxidative and Neuroprotective Actions.

Inhibition of USP1 ameliorates hypertensive nephropathy through regulating oxidative stress and ferroptosis: A precise treatment via SJB3-019A nanodelivery

Cu-Doping Layered Double Hydroxides Nanozyme Integrated with Nitric Oxide Donor for Enhanced Antioxidant Therapy in Retinopathy

Superoxide Dismutase‐Loaded Nanoparticles Attenuate Myocardial Ischemia‐Reperfusion Injury and Protect against Chronic Adverse Ventricular Remodeling

Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation

Nano-integrated cascade antioxidases opsonized by albumin bypass the blood-brain barrier for treatment of ischemia-reperfusion injury

1039 ACE2 DEFICIENCY FACILIATES ANGIOTENSIN II-MEDIATED VASCULAR PEROXYNITRITE PRODUCTION WITH ACTIVATION OF THE AKT/ENOS SIGNALING

A Redox Modulatory Sod Mimetic Nanozyme Prevents The Formation of Cytotoxic Peroxynitrite And Improves Nitric Oxide Bioavailability in Human Endothelial Cells

Nanoparticles for Targeted Delivery of Antioxidant Enzymes to the Brain after Cerebral Ischemia and Reperfusion Injury

Salvaging Brain Ischemia by Increasing Neuroprotectant Uptake Via Nanoagonist Mediated Blood Brain Barrier Permeability Enhancement